These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Peptidomimetic competitive inhibitors of protein tyrosine phosphatases. Shen K; Qi L; Stiff L Curr Pharm Des; 2010; 16(28):3101-17. PubMed ID: 20687872 [TBL] [Abstract][Full Text] [Related]
3. Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics. Groves MR; Yao ZJ; Roller PP; Burke TR; Barford D Biochemistry; 1998 Dec; 37(51):17773-83. PubMed ID: 9922143 [TBL] [Abstract][Full Text] [Related]
4. Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action. Bleasdale JE; Ogg D; Palazuk BJ; Jacob CS; Swanson ML; Wang XY; Thompson DP; Conradi RA; Mathews WR; Laborde AL; Stuchly CW; Heijbel A; Bergdahl K; Bannow CA; Smith CW; Svensson C; Liljebris C; Schostarez HJ; May PD; Stevens FC; Larsen SD Biochemistry; 2001 May; 40(19):5642-54. PubMed ID: 11341829 [TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel submicromolar inhibitor of the lymphoid specific tyrosine phosphatase. Xie Y; Liu Y; Gong G; Rinderspacher A; Deng SX; Smith DH; Toebben U; Tzilianos E; Branden L; Vidović D; Chung C; Schürer S; Tautz L; Landry DW Bioorg Med Chem Lett; 2008 May; 18(9):2840-4. PubMed ID: 18434147 [TBL] [Abstract][Full Text] [Related]
6. Phospho-Azatyrosine, a less effective protein-tyrosine phosphatase substrate than phosphotyrosine. Burke TR; Yao ZJ; Ye B; Miyoshi K; Otaka A; Wu L; Zhang ZY Bioorg Med Chem Lett; 2001 May; 11(10):1265-8. PubMed ID: 11392533 [TBL] [Abstract][Full Text] [Related]
7. High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45. Stanford SM; Panchal RG; Walker LM; Wu DJ; Falk MD; Mitra S; Damle SS; Ruble D; Kaltcheva T; Zhang S; Zhang ZY; Bavari S; Barrios AM; Bottini N Proc Natl Acad Sci U S A; 2012 Aug; 109(35):13972-7. PubMed ID: 22891353 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of the lymphoid tyrosine phosphatase: the effect of zinc(II) ions and chelating ligand fragments on enzymatic activity. Thorson MK; Puerta DT; Cohen SM; Barrios AM Bioorg Med Chem Lett; 2014 Aug; 24(16):4019-22. PubMed ID: 24997687 [TBL] [Abstract][Full Text] [Related]
9. 4'-O-[2-(2-fluoromalonyl)]-L-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides. Burke TR; Ye B; Akamatsu M; Ford H; Yan X; Kole HK; Wolf G; Shoelson SE; Roller PP J Med Chem; 1996 Mar; 39(5):1021-7. PubMed ID: 8676336 [TBL] [Abstract][Full Text] [Related]
10. 6,8-Difluoro-4-methylumbiliferyl phosphate: a fluorogenic substrate for protein tyrosine phosphatases. Welte S; Baringhaus KH; Schmider W; Müller G; Petry S; Tennagels N Anal Biochem; 2005 Mar; 338(1):32-8. PubMed ID: 15707933 [TBL] [Abstract][Full Text] [Related]
11. pCAP-based peptide substrates: the new tool in the box of tyrosine phosphatase assays. Stanford SM; Krishnamurthy D; Kulkarni RA; Karver CE; Bruenger E; Walker LM; Ma CT; Chung TD; Sergienko E; Bottini N; Barrios AM Methods; 2014 Jan; 65(2):165-74. PubMed ID: 23886911 [TBL] [Abstract][Full Text] [Related]
12. Light-switched inhibitors of protein tyrosine phosphatase PTP1B based on phosphonocarbonyl phenylalanine as photoactive phosphotyrosine mimetic. Wagner S; Schütz A; Rademann J Bioorg Med Chem; 2015 Jun; 23(12):2839-47. PubMed ID: 25907367 [TBL] [Abstract][Full Text] [Related]
13. Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. Doman TN; McGovern SL; Witherbee BJ; Kasten TP; Kurumbail R; Stallings WC; Connolly DT; Shoichet BK J Med Chem; 2002 May; 45(11):2213-21. PubMed ID: 12014959 [TBL] [Abstract][Full Text] [Related]
15. High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry. Tan LP; Wu H; Yang PY; Kalesh KA; Zhang X; Hu M; Srinivasan R; Yao SQ Org Lett; 2009 Nov; 11(22):5102-5. PubMed ID: 19852491 [TBL] [Abstract][Full Text] [Related]
16. Potent inhibition of protein-tyrosine phosphatase-1B using the phosphotyrosyl mimetic fluoro-O-malonyl tyrosine (FOMT). Roller PP; Wu L; Zhang ZY; Burke TR Bioorg Med Chem Lett; 1998 Aug; 8(16):2149-50. PubMed ID: 9873503 [TBL] [Abstract][Full Text] [Related]
17. Covalent inhibition of the lymphoid tyrosine phosphatase. Ahmed VF; Bottini N; Barrios AM ChemMedChem; 2014 Feb; 9(2):296-9. PubMed ID: 24403103 [TBL] [Abstract][Full Text] [Related]
18. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors. Burke TR; Yao ZJ; Liu DG; Voigt J; Gao Y Biopolymers; 2001; 60(1):32-44. PubMed ID: 11376431 [TBL] [Abstract][Full Text] [Related]
19. Potent inhibition of protein-tyrosine phosphatase by phosphotyrosine-mimic containing cyclic peptides. Akamatsu M; Roller PP; Chen L; Zhang ZY; Ye B; Burke TR Bioorg Med Chem; 1997 Jan; 5(1):157-63. PubMed ID: 9043667 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of imidazolidine-2,4-dione and 2-thioxothiazolidin-4-one derivatives as lymphoid-specific tyrosine phosphatase inhibitors. Liang X; Fu H; Xiao P; Fang H; Hou X Bioorg Chem; 2020 Oct; 103():104124. PubMed ID: 32768742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]